Biggest News Aggregation in the World
📰 Divi Lab News

Page 19 - Divi Lab News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Divi Lab. Real-time updates on events, politics, business and more.

market outlook: Ahead of Market: 12 things that will decide stock action on Friday

US stocks rise as focus turns to stimulus, corporate earnings Wall Streets main indexes gained on Thursday, as investors looked to corporate earnings and signs of progress on a pandemic-relief package after data suggested the labor market was stabilizing. The Dow Jones Industrial Average rose 265.2 points, or 0.86% to 30,989.11. The S&P 500 rose 23.92 points, or 0.61% to 3,854.07, while the Nasdaq Composite rose 74.95 points, or 0.55%, to 13,684.96. European shares strengthen on recovery hopes ...
India General Ajit Mishra Marksans Pharma Nagaraj Shetti Vinod Nair Head Of Research

Divi's Lab, one of best performing large-cap stocks, sees wave of bullish calls

Divi’s Lab, one of best performing large-cap stocks, sees wave of bullish calls Premium (REUTERS) Ronojoy Mazumdar , Bloomberg Overall in absolute terms, analysts’ average 12-month target price for Divi’s stock has risen about ₹134 in the past four weeks Share Via Some analysts are turning even more bullish on India’s best-performing large-cap stock in 2020. In just about two weeks, at least four brokerages have raised their price targets on Divi’s Laboratories Ltd., one of the to...
Andhra Pradesh Tushar Manudhane Bharti Airtel Siddhant Khandekar Abhishek Sharma India Health Care Index

Vaccine progress adds to growth opportunities for Dr Reddy's

Vaccine progress adds to growth opportunities for Dr Reddy’s Premium A vial of the Russian Sputnik V coronavirus vaccine is pictured in Belgrade, Serbia, January 6, 2021. REUTERS/Fedja Grulovic (REUTERS) The success of the vaccine can improve the companys prospects that has been witnessing strong growth momentum in key markets. While many manufacturers have lined up their vaccines, analysts say there will be sufficient demand to consume at least 100 million doses in India Share Via Read Full...
Andhra Pradesh Bharti Airtel Spicejet Ltd Divi Lab Motilal Oswal Financial Services Russian Direct Investment Fund

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Saurabh Mukherjea: Invest in recovery but don't get suckered into low quality smallcaps: Saurabh Mukherjea

It is turning out to be quite a stellar market after the Monday slide. How are you reading into the situation given the new Covid strain in the UK and lots of clampdowns coming in globally. It seems Indian markets are not taking too much notice? We have to realise that the vaccinations across the world will take a long time. I have been speaking to my friends and relatives in the UK but it is going very slowly and it does not look like anytime in the next 12 months we will be done with this who...
United Kingdom Sun Pharma Saurabh Mukherjea Maruti Suzuki Yusuf Hamied Divi Lab

Ahead of Market: 12 things that will decide stock action on Monday

Ahead of Market: 12 things that will decide stock action on Monday SECTIONS Share Shutterstock.com As many as 200 stocks on the BSE 500 index settled the day in green, while 296 settled the day in red. NEW DELHI: Nifty formed an indecisive candle on the daily chart on Friday after it closed on a positive note for the seventh consecutive week. Shrikant Chouhan, Executive Vice President, Equity Technical Research, Kotak Securities, said, "For the next few trading sessions, 13,650 should be the s...
United States Vikas Nigam Mazhar Mohammad Shrikant Chouhan Lemon Tree Hotels Central Bank

Here is a Bull Spread Strategy on Divi's Lab by Nandish Shah of HDFC Sec

Bull spread Strategy on Divis Lab Buy Divis Lab Dec 3850 Call at Rs 105 & simultaneously sell Dec 4000 Call at Rs 53 Lot Size: 200 Cost of the strategy: Rs 52 (Rs 10400 per strategy) Maximum profit: Rs 19,600 if Divis Lab closes at or above 4,000 till 31 Dec expiry. Breakeven Point Rs 3,902 Rationale: Short covering was seen in the Divis Lab Futures where we have seen 1 per cent fall in the Open Interest with price rising by 3 per cent. The stock Price has broken out on the daily chart...
Divi Lab Nandish Shah Is Technical Research Analyst Divi Lab Dec Lab Dec Lab Future Open Interest

Post Market views - Dec 17, 2020 - Mr. Binod Modi, Head Strategy at Reliance Securities

Post Market views - Dec 17, 2020 - Mr. Binod Modi, Head Strategy at Reliance Securities Posted On: 2020-12-17 05:08:59 (Time Zone: Arizona, USA) Domestic equities remained upbeat and recorded fresh highs. A dovish tone of Federal Reserve along with assurance of continuing asset purchase program until economy makes a substantial progress bolstered investors sentiment. Financials and Pharma continued to outperform and supported market. HDFC twins, Divis Lab and Bajaj Finance were among top g...
Divi Lab Federal Reserve Binod Modi Head Strategy Bajaj Finance Asian Paints

market analysis: F&O: Bulls holding a tight grip; buying happening on every dip

Explore Now Nifty opened positive on Thursday and continued its upward move towards a new lifetime high at the 13,773 mark. The index continued its winning streak for the fifth consecutive session and closed with a gain of more than 50 points. It formed a small bullish candle on the daily chart towards 13,850 and then 14,000 levels, while on the downside support exists at 13,500 level. India VIX slipped marginally by 0.22% from 19.20 to 19.15 level. The overall lower volatility suggests the bul...
Jubiland Foodworks Bank Nifty Divi Lab Page Industries Berger Paint Bajaj Finance

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science